Williams SC, Schmaltz SP, Morton DJ, Koss RG, Loeb JM. Quality of care in U.S. hospitals as reflected by standardized measures, 2002–2004. N Engl J Med. 2005; 353:255–64.
Lindenauer PK, Remus D, Roman S, Rothberg MB, Benjamin EM, Ma A, Bratzler DW. Public reporting and pay for performance in hospital quality improvement. N Engl J Med. 2007; 356:486–96.
Perkins C, Balma D, Garcia R; Members of the Consensus Group; Susan G. Komen for the Cure. Why current breast pathology practices must be evaluated. A Susan G. Komen for the Cure white paper: June 2006. Breast J. 2007; 13:443–7.
Buyske J. For the protection of the public and the good of the specialty: maintenance of certification. Arch Surg. 2009; 144:101–3.
Kaufman CS, Shockney L, Rabinowitz B, et al. National Quality Measures for Breast Centers (NQMBC): a robust quality tool: breast center quality measures. Ann Surg Oncol. 2010; 17:377–85.
Del Turco MR, Ponti A, Bick U, et al. Quality indicators in breast cancer care. Eur J Cancer. 2010; 46:2344–56.
Desch CE, McNiff KK, Schneider EC, et al. American Society of Clinical Oncology/National Comprehensive Cancer Network quality measures. J Clin Oncol. 2008; 26:3631–7.
Jara Sánchez C, Ruiz A, Martín M, et al. Influence of timing of initiation of adjuvant chemotherapy over survival in breast cancer: a negative outcome study by the Spanish Breast Cancer Research Group (GEICAM). Breast Cancer Res Treat. 2007; 101:215–23.
Cold S, Du ̈ring M, Ewertz M, Knoop A, Moller S. Does timing of adjuvant chemotherapy influence the prognosis after early breast cancer? Results of the Danish Breast Cancer Cooperative Group (DBCG). Br J Cancer. 2005; 93:627–32.
Brazda A, Estroff J, Euhus D, et al. Delays in time to treatment and survival impact in breast cancer. Ann Surg Oncol. 2010; 17 Suppl 3:291–6.
Comber H, Cronin DP, Deady S, Lorcain PO, Riordan P. Delays in treatment in the cancer services: impact on cancer stage and survival. Ir Med J. 2005; 98:238–9.
Colleoni M, Bonetti M, Coates AS, et al. Early start of adjuvant chemotherapy may improve treatment outcome for premenopausal breast cancer patients with tumors not expressing estrogen receptors. The International Breast Cancer Study Group. J Clin Oncol. 2000; 18:584–90.
Hershman DL, Wang X, McBride R, Jacobson JS, Grann VR, Neugut AL. Delay of adjuvant chemotherapy initiation following breast cancer surgery among elderly women. Breast Cancer Res Treat. 2006; 99:313–21.
Lohrisch C, Paltiel C, Gelmon K, Speers C, Taylor S, Barnett J, Olivoto IA. Impact on survival of time from definitive surgery to initiation of adjuvant chemotherapy for early-stage breast cancer. J Clin Oncol. 2006; 24:4888–94.
Bleicher RJ, Ruth K, Sigurdson ER, et al. Time to surgery and breast cancer survival in the United States. JAMA Oncol. 2016; 2:330–9.
Vandergrift JL, Niland JC, Theriault RL, et al. Time to adjuvant chemotherapy for breast cancer in National Comprehensive Cancer Network institutions. J Natl Cancer Inst. 2013; 105:104–12.
Gagliato Dde M, Gonzalez-Angulo AM, LeiX, et al. Clinical impact of delaying initiation of adjuvant chemotherapy in patients with breast cancer. J Clin Oncol. 2014; 32:735–44.
Chavez-MacGregor M, Clarke CA, Lichtensztajn DY, Giordano SH. Delayed initiation of adjuvant chemotherapy among patients with breast cancer. JAMA Oncol. 2015; 2:322–9.
Edge SBBD, Compton CC, Fritz AG, Greene FL, Trotti A, ed. AJCC Cancer Staging Manual.7th ed. New York, NY: Springer; 2010.
Raval MV, Bilimoria KY, Stewart AK, Bentrem DJ, Ko CY. Using the NCDB for cancer care improvement: an introduction to available quality assessment tools. J Surg Oncol. 2009; 99:488–90.
Cole, S. R. and Hernán, M. A. Adjusted survival curves with inverse probability weights. Comput Methods Prog Biomed. 2004; 75:45–49.